Aaron Larsen
Aaron is the CSO of Terrain Biosciences, a startup producing the world’s highest-quality mRNA to power biotechnology innovation. After earning a PhD in Chemistry at McGill, Aaron studied RNA as a NASA and HHMI fellow at Harvard in Nobel laureate Jack Szostak’s lab. He then joined Moderna as an early employee, contributing to mRNA technologies now used in the COVID vaccine and personalized cancer vaccine in trials. Aaron later led RNA platforms at Beam Therapeutics, overseeing mRNA and guide RNA production, including the first GMP campaigns. At Resilience Therapeutics, he directed nucleic acid R&D and GMP manufacturing of plasmid DNA, oligos, mRNA and LNPs at pre-clinical and clinical scales. Aaron’s career reflects deep expertise in advancing RNA science and its applications.
Terrain Biosciences
Pushing Boundaries: How Reliable DNA Synthesis is Accelerating Innovation in Cell and Gene Therapy
-
Join leading scientists as they share how increased reliability in DNA synthesis services is transforming the way they work—empowering them to confidently expand their design space, accelerate project timelines, and drive innovation in vaccine development and cell and gene therapies. Scientists will talk about their experiences with vector onboarding, synthesis of long and complex sequences, and chromosomal and genome engineering.
